Soluble immune checkpoint molecules: Serum markers for cancer diagnosis and prognosis.
Rituparna ChakrabartiBhavya KapseGayatri MukherjeePublished in: Cancer reports (Hoboken, N.J.) (2019)
Several studies demonstrate that the serum levels of these soluble isoforms could be used as noninvasive markers for cancer diagnosis and disease prognosis or to predict patient response to specific therapeutic strategies.